News Archive
Beckman Coulter Life Sciences today announces an expansion of its CARES Initiative at the 2015 International AIDS Society (IAS) Conference.
MP Biomedicals CEO Milan Panic and RUSNANO CEO Anatoly Chubais have signed an agreement of cooperation. The parties have agreed to cooperate in the areas of nanotechnology research and development, in creation and modernization of an R&D base, and in providing due conditions for production of innovative pharmaceuticals, including personal pharmacogenetic treatments.
Using a novel genetic technology that covers up genetic errors, researchers funded in part by the National Institutes of Health have developed a successful treatment for dogs with the canine version of Duchenne muscular dystrophy, a paralyzing, and ultimately fatal, muscle disease.
"'First world' health problems such as obesity and heart disease may be gaining ground in developing nations, but they are mostly afflicting the rich and middle class while poor people remain undernourished and underweight," according to a study published in the American Journal of Clinical Nutrition, Reuters reports.
A new study on cocaine, the notorious white powder illegally snorted, injected or smoked by nearly 2 million Americans, details how it may permanently damage proteins in the body. That information, gleaned from laboratory tests, could be used to potentially detect the drug in biofluids for weeks or months - instead of days - after use, say scientists. The findings, which appear in the ACS journal Chemical Research in Toxicology, could also help explain cocaine's long-term health effects.
› Verified 6 days ago